DiaMedica Therapeutics (DMAC) Capital Expenditures (2018 - 2026)
DiaMedica Therapeutics (DMAC) reported Capital Expenditures of $8000.0 for Q1 2026, down 33.33% on a YoY basis from $12000.0 in Q1 2025, and up 33.33% quarter-over-quarter from $6000.0 in Q4 2025.
DiaMedica Therapeutics (DMAC) Capital Expenditures (2018 - 2026) Analysis & Trends
DiaMedica Therapeutics has reported Capital Expenditures for 9 years, with the latest figure at $8000.0 in Q1 2026.
- For the quarter ending Q1 2026, Capital Expenditures fell 33.33% year-over-year to $8000.0; the trailing twelve-month figure through Mar 2026 stood at $36000.0 (up 28.57% YoY), and the FY2025 full-year result was $40000.0, up 60.0% from the prior year.
- Capital Expenditures for Q1 2026 stood at $8000.0, up from $6000.0 in the prior quarter.
- The five-year high for Capital Expenditures was $43000.0 in Q3 2022, with the low at $3000.0 in Q4 2023.
- Historically, Capital Expenditures has averaged $11866.7 across 5 years, with a median of $8000.0 in 2026.
- Annual changes were most pronounced in 2022 — Capital Expenditures soared 2050.0% — and 2023, when it sank 90.62%.
- DiaMedica Therapeutics' Capital Expenditures stood at $32000.0 in 2022, then slumped by 90.62% to $3000.0 in 2023, then soared by 133.33% to $7000.0 in 2024, then decreased by 14.29% to $6000.0 in 2025, then jumped by 33.33% to $8000.0 in 2026.
- The last three Capital Expenditures figures came in at $8000.0 (Q1 2026), $6000.0 (Q4 2025), and $16000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 133.40 Mn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | -63,220.27 |
| 10 | DiaMedica Therapeutics | 285.11 Mn | 233.77 Mn | - | 8,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8,000.00 |
| Mar 31, 2026 | 8,000.00 |
| Dec 31, 2025 | 6,000.00 |
| Dec 31, 2025 | 6,000.00 |
| Sep 30, 2025 | 16,000.00 |
| Sep 30, 2025 | 16,000.00 |
| Jun 30, 2025 | 6,000.00 |
| Jun 30, 2025 | 6,000.00 |
| Mar 31, 2025 | 12,000.00 |
| Mar 31, 2025 | 12,000.00 |
| Dec 31, 2024 | 7,000.00 |
| Dec 31, 2024 | 7,000.00 |
| Sep 30, 2024 | 9,000.00 |
| Sep 30, 2024 | 9,000.00 |
| Mar 31, 2024 | 9,000.00 |
| Mar 31, 2024 | 9,000.00 |
| Dec 31, 2023 | 3,000.00 |
| Dec 31, 2023 | 3,000.00 |
| Sep 30, 2023 | 10,000.00 |
| Sep 30, 2023 | 10,000.00 |